Arthritis impacts more than a quarter of adults in the United States. Learn more about your options for managing this disorder in this post.
GIOSTAR Chicago reviews in greater detail the potential for mesenchymal stem cells (MSCs) to reduce inflammation. This may provide benefit to patients suffering from multiple sclerosis, rheumatoid arthritis, and other autoimmune disorders.
Patients are finding effective alternatives to surgery for managing arthritis, knee injuries, shoulder pain, and other orthopedic injuries, with regenerative medicine.